May 15: Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products - In Person at ISPOR 2022
8:00AM–12:00PM Eastern Daylight Time (EDT)
During the recent years, Managed Entry Agreements (MEAs) have become instrumental in ensuring the access of the innovative medicines. This course is designed for health care professionals (including public decision-makers, academia and industry) involved in pricing and reimbursement decisions who are wishing to understand the applicability and technical aspects of managed entry agreements (MEAs) in countries with severe economic constraints and explicit cost-effectiveness criterion. The topic will be introduced with key features of pricing and reimbursement systems in Central-Eastern European countries to understand why special methods are needed to facilitate evidence-based reimbursement policies of new health technologies. Faculty will present an economic model to explain the methodology and implications of managed entry agreements in cost-effectiveness and budget impact analysis. Participants will then have the opportunity to apply what they have learned through a hands-on exercise on making pricing and reimbursement decisions. A decision algorithm will be presented to support evidence and value-based policy decisions of high-cost new technologies in CEE countries. A series of password protected economic models will add more and more complexity to a pragmatic case study on a new pharmaceutical product in oncology. To close the course faculty will lead a discussion on the applicability of a pragmatic decision tool illustrating the pros and cons of different managed entry agreements and their usefulness in CEE settings. Participants who wish to gain hands-on experience must bring their laptops with Microsoft Excel for Windows installed.
Louis P Garrison, PhD
University of Washington
Seattle, WA, USA
Adrian Towse, MA, MPhil
Office of Health Economics
London, UK
Josh J Carlson, MPH, PhD
University of Washington
Seattle, WA, USA
May 15, 2022
Back to all short courses
Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products
LEVEL: Intermediate
TRACK: Health Policy & Regulatory
LENGTH: 4 Hours | Course runs 1 day
This short course will be offered in-person at the ISPOR 2022 conference. Separate registration is required. Visit the ISPOR 2022 website to register and learn more.
8:00AM–12:00PM Eastern Daylight Time (EDT)
DESCRIPTION
During the recent years, Managed Entry Agreements (MEAs) have become instrumental in ensuring the access of the innovative medicines. This course is designed for health care professionals (including public decision-makers, academia and industry) involved in pricing and reimbursement decisions who are wishing to understand the applicability and technical aspects of managed entry agreements (MEAs) in countries with severe economic constraints and explicit cost-effectiveness criterion. The topic will be introduced with key features of pricing and reimbursement systems in Central-Eastern European countries to understand why special methods are needed to facilitate evidence-based reimbursement policies of new health technologies. Faculty will present an economic model to explain the methodology and implications of managed entry agreements in cost-effectiveness and budget impact analysis. Participants will then have the opportunity to apply what they have learned through a hands-on exercise on making pricing and reimbursement decisions. A decision algorithm will be presented to support evidence and value-based policy decisions of high-cost new technologies in CEE countries. A series of password protected economic models will add more and more complexity to a pragmatic case study on a new pharmaceutical product in oncology. To close the course faculty will lead a discussion on the applicability of a pragmatic decision tool illustrating the pros and cons of different managed entry agreements and their usefulness in CEE settings. Participants who wish to gain hands-on experience must bring their laptops with Microsoft Excel for Windows installed.
***Registrants will receive a digital course book. Copyright, Trademark and Confidentiality Policies apply.***
FACULTY MEMBERSLouis P Garrison, PhD
University of Washington
Seattle, WA, USA
Adrian Towse, MA, MPhil
Office of Health Economics
London, UK
Josh J Carlson, MPH, PhD
University of Washington
Seattle, WA, USA
Basic Schedule:
4 Hours | Course runs 1 Day